04:25 PM EDT, 07/02/2024 (MT Newswires) -- Gyre Therapeutics ( GYRE ) said Tuesday it has received approval in China for avatrombopag maleate tablets for the treatment of low blood platelet count associated with chronic liver disease. The drug is approved for adult patients undergoing elective diagnostic procedures or therapy. Gyre Therapeutics' ( GYRE ) unit Gyre Pharmaceuticals acquired avatrombopag...

04:16 PM EDT, 07/02/2024 (MT Newswires) -- Inovio Pharmaceuticals ( INO ) said Tuesday it has appointed Steven Egge as chief commercial officer. Egge was most recently senior vice president and general manager for women's health at Sumitomo Pharma, Inovio said. Shares of Inovio were up 0.6% in after-hours activity. Price: 8.48, Change: +0.05, Percent Change: +0.59 ...

04:21 PM EDT, 07/02/2024 (MT Newswires) -- Innocan Pharma ( INNPF ) said Tuesday it engaged the Past-President of the Eastern Pain Association, Dr. William K. Schmidt, to support its LPT-CBD submission process to the Food and Drug Administration for chronic pain. Dr. Schmidt brings over 25 years of pharmaceutical industry clinical trial experience, specializing in analgesic and narcotic antagonist...

04:23 PM EDT, 07/02/2024 (MT Newswires) -- Marion McCourt, Executive Vice President, Commercial, on July 01, 2024, sold 1,137 shares in Regeneron Pharmaceuticals ( REGN ) for $1,190,564. Following the Form 4 filing with the SEC, McCourt has control over a total of 13,105 shares of the company, with 12,931 shares held directly and 174 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/872589/000196820224000106/xslF345X03/edgardoc.xml...